Feedback / Questions
lomibuvir (VX 222) - Trek Therapeutics
Vertex: Annual Report 2012
(Vertex)
-
Mar 14, 2013 -
Anticipated patent expiry in US in 2030; Anticipated patent expiry in EU in 2027
Anticipated patent expiry
•
Hepatitis C Virus
http://files.shareholder.com/downloads/VRTX/2276229301x0xS875320-13-9/875320/filing.pdf
Mar 14, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.